Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gamida Cell Receives Recommendation To Continue StemEx Phase III Study
Reportedly, the next data analysis is anticipated to take place during Q2 2010. StemEx is being evaluated as a therapeutic treatment for adolescents and adults with blood cancers
Reportedly, the next data analysis is anticipated to take place during Q2 2010. StemEx is being evaluated as a therapeutic treatment for adolescents and adults with blood cancers
A paper entitled ‘A Placebo-Controlled Trial of Microplasmin Intravitreous Injection to Facilitate Posterior Vitreous Detachment Before Vitrectomy’, has been published online ahead of print in Ophthalmology. This publication
The official opening ceremony was performed by Friedrich Conzen, major of Dusseldorf. Dr Simon Moroney, chief executive officer of MorphoSys Group, also attended along with Dieter Feger, Head
The agreement to purchase Topigen was announced to the market on 12 January, 2010. An additional 5.0 million shares will be issued subject to the achievement of certain
The trial investigated five ascending doses of PXS25 in 40 subjects. At all doses, PXS25 was found to be safe and well tolerated with a pharmacokinetic profile consistent
CytoSolv is a newly formed Rhode Island biomedical company, developing proprietary technology to address wound healing, initially targeting diabetic ulcers. Its technology involves the delivery of a mixture
The trial was based on age (men= 50 and women= 60), high-sensitivity C-reactive protein (hsCRP) = 2mg/l, and the presence of at least one additional CVD risk factor,
Labetalol HCl Injection is the generic equivalent of Prometheus Laboratories’ Trandate (Labetalol HCl) Injection. Labetalol HCl Injection is an adrenergic receptor blocking agent that has both selective alpha1-adrenergic
Kevin Hrusovsky, president and CEO of Caliper Life Sciences, said: “We have partnered with key thought leaders and customers to create the Sciclone G3 platform, which expands Caliper’s
The patent, titled ‘Catalysts,’ US 7,651,875, was issued by the US Patent and Trademark Office (USPTO) on January 26. It covers some of the many potential applications of